Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0K0IN
|
|||
| Former ID |
DIB001159
|
|||
| Drug Name |
KBSA-301
|
|||
| Synonyms |
KBSA-201; Human IgG monoclonal antibodies (Staphylococcus aureus infection), Kenta Biotech
Click to Show/Hide
|
|||
| Indication | Staphylococcus infection [ICD-11: 1B5Y] | Phase 1 | [1] | |
| Company |
Kenta Biotech Ltd
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01589185) Safety, Pharmacokinetics and Efficacy of KBSA301 in Severe Pneumonia (S. Aureus). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.